Aridis Pharmaceuticals Inc (NASDAQ:ARDS)
| 0.29 Delayed Data As of 3:58pm ET |  +0.0052 / +1.83%Today’s Change | 0.15 Today|||52-Week Range 2.77 | -75.42% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Operating Activities | Net Income / Starting Line | -1.4M | -7.9M | -5.4M | -8.1M | |
| Depreciation | 73.0K | 76.0K | 83.0K | 81.0K | ||
| Total Other Cash Flow | -2.7M | 1.8M | 415.0K | 892.0K | ||
| Funds From Operations | -4.1M | -6.0M | -4.9M | -7.1M | ||
| Funds From/For Other Operating Expenses | 2.2M | -1.3M | 3.9M | 724.0K | ||
| Net Cash Flow - Operating Activities | -6.3M | -4.7M | -8.8M | -7.8M | ||
| Investing | Increase In Investments | 0.00 | 0.00 | -1.0M | 0.00 | |
| Capital Expenditures | -647.0K | 242.0K | 0.00 | -120.0K | ||
| Net Cash Flow Investing | -647.0K | 242.0K | -1.0M | -120.0K | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 0.00 | 25.1M | 9.0K | 8.0K | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 0.00 | 25.1M | 9.0K | 8.0K | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | -6.9M | 20.6M | -9.8M | -7.9M | ||
